Related Experiment Videos
Thymine-requiring bacteria associated with co-trimoxazole therapy
Lancet (London, England)
|April 17, 1976
Summary
Thymine-requiring (thy-) bacterial mutants can emerge during prolonged co-trimoxazole treatment in patients with renal calculi or chronic chest infections. Promptly changing antimicrobials is crucial upon detecting these resistant pathogens.
Area of Science:
- Microbiology
- Clinical Medicine
- Pharmacology
Background:
- Thymine-requiring (thy-) bacterial mutants have been isolated from patients with specific infections.
- These isolations occurred after prolonged co-trimoxazole treatment.
Purpose of the Study:
- To investigate the development of thy- mutants in patients undergoing co-trimoxazole therapy.
- To understand the clinical implications and identify factors contributing to mutant emergence.
Main Methods:
- Isolation and identification of thy- mutants from patient samples (urine, sputum).
- Utilized diagnostic sensitivity test agar (deficient in thymine) for mutant identification.
- Assessed the role of wild-type bacteria and patient urine in supporting mutant growth in vitro.
Main Results:
- Thy- mutants were isolated from 8 patients with renal calculi and 1 with chronic chest infection.
- Persistent pyuria and purulent sputum were noted in affected patients.
- Wild-type bacteria and urine compounds supported in vitro growth of thy- mutants, suggesting nutrient availability.
Conclusions:
- Co-trimoxazole therapy can lead to the development of thy- mutants, particularly in renal calculi.
- Early detection and change of antimicrobial therapy are recommended upon identification of mutant infections.